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SYNOPSIS 
Binge-eating disorder (BED), first included as a diagnostic entity in the Diagnostic and 
Statistical Manual of Mental Disorders Fifth Edition, is characterized by recurrent episodes of 
binge eating without regular compensatory behaviors to prevent weight gain. With a complex 
multifactorial etiology, BED is the most frequent eating disorder co-occuring with significant 
psychopathology, mental and physical comorbidity, obesity, and life impairment. Despite its 
significance, BED is not sufficiently recognized, diagnosed, or treated. Evidence-based 
treatments for BED include psychotherapy and structured self-help treatment, with cognitive-
behavioral therapy as most well-established approach, and pharmacotherapy with 
lisdexamfetamine as FDA approved medication with a limitation of use. 
The final publication is available at https://doi.org/10.1016/j.psc.2018.10.011
KEY POINTS 
‐ Binge-eating disorder is a clinical eating disorder characterized by recurrent binge 
eating in the absence of regular compensatory behaviors to prevent weight gain. 
‐ Being the most frequent eating disorder, binge-eating disorder co-occurs with 
significant psychopathology, mental and physical comorbidity, obesity, and life 
impairment. 
‐ Despite its significance, binge-eating disorder is not sufficiently being recognized, 
diagnosed, and treated. 
‐ Evidence-based treatments for binge-eating disorder mainly include psychotherapy 
and structured self-help treatment, with cognitive-behavioral therapy being the most 
well-established approach, as well as pharmacotherapy. 
‐ Lisdexamfetamine is FDA approved for binge-eating disorder with a limitation of use. 
 
  
Binge-eating disorder (BED) was first included as its own diagnostic entity in the Fifth 
Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) within the 
Feeding and Eating Disorders section.1 BED’s hallmark feature is recurrent binge eating, 
involving the consumption of an amount of food that is definitively larger than what others 
would eat under comparable circumstances within a certain time, associated with a feeling of 
loss of control over eating. Diagnosis of BED according to DSM-5 (307.59) requires this 
objective binge eating to occur at least once per week over 3 months. In contrast to binge 
eating in bulimia nervosa, binge eating in BED occurs without regular inappropriate 
compensatory behaviors aimed at preventing weight gain, such as self-induced vomiting, 
fasting, or laxative misuse. Binge eating in BED is further characterized by behavioral 
abnormalities, such as eating rapidly or until feeling uncomfortably full, and results in marked 
distress.  
 The DSM-5 offers two specifications for the diagnosis of BED: current severity as 
indicated by the weekly frequency of binge eating; and partial or full remission status after 
meeting full criteria of BED. In addition, within the Other Specified Feeding or Eating 
Disorders, DSM-5 newly defines a lower-threshold form of BED (307.59), also associated 
with significant distress or impairment in life functioning: BED of low frequency and/or 
limited duration can be diagnosed if objective binge eating is occurring less than once per 
week and/or for shorter than 3 months, while all other DSM-5 criteria of BED still need to be 
met. 
 The International Classification of Diseases and Related Health Problems Tenth 
Edition (ICD-10)2 subsumed BED under the Other Eating Disorders (F50.8), without any 
further specific diagnostic criteria. For the Eleventh Edition of ICD (ICD-11), scheduled for 
2019, BED was designated as its own eating disorder diagnosis. Deviating from the DSM-5, 
the ICD-11 diagnosis of BED was proposed to be broadened and based on both objective or 
subjective binge eating, termed “loss of control eating.” Loss of control eating is characterized 
as eating an objectively or subjectively large amount of food, while experiencing a sense of 
loss of control over eating. While the sense of loss of control is a well-validated feature of 
binge eating, it has been cautioned that the size of a binge provides only incremental 
information in the explanation of illness severity and psychopathology in diverse eating 
disorders,3 so that the clinical significance of this proposed diagnosis of BED may be 
decreased. 
 
CLINICAL PRESENTATION  
Establishing BED as its own diagnostic entity in DSM-51 was based on extant literature 
demonstrating the clinical significance of this disorder. Individuals with BED suffer from 
increased eating disorder (e.g., weight and shape concern) and general psychopathology (e.g., 
depressiveness, anxiety), and high comorbidity with mood disorders, anxiety disorders, and 
substance use disorders, and personality disorders, notably borderline personality disorder, 
when compared to individuals without BED, and individuals with or without obesity. 
Additionally, BED frequently co-occurs with attention-deficit/hyperactivity disorder.4 Thus, 
BED displays similar psychological impairments as the other well-defined eating disorders, 
anorexia nervosa and bulimia nervosa.  
 In addition to psychological comorbidity, BED frequently co-occurs with obesity 
(body mass index, BMI ≥ 30.0 kg/m2). Because of this comorbidity, individuals with BED 
have an increased risk of the obesity-related medical sequelae, for example, type 2 diabetes 
mellitus, hypertension, and dyslipidemia, and of premature mortality.5,6 Further health conditions 
increased in individuals with BED include asthma, gastrointestinal symptoms, sleep and pain 
disorders, neurological problems, and gynecological conditions.7,8  
 The eating behavior in BED is characterized by a general tendency toward overeating. 
In laboratory test meal studies, individuals with BED overate during both binge-eating and 
non-binge-eating meals when compared to weight-matched controls.9 They described more 
variable meal patterns including more snacking, nibbling, or double meals.10 When compared 
to bulimia nervosa, individuals with BED displayed lower dietary restraint and actual 
restriction,11 although they exhibited a pronounced body image disturbance.12 Further, they 
indicated greater craving, emotional eating, eating for coping purposes,13 and greater hedonic 
hunger than controls, and thus experience a greater motivation to eat for pleasure while not in 
caloric need.14  
 BED results in significant decreases in health-related quality of life and social function 
impairment, which is similar to the other defined eating disorders.15,16 Also underlining the 
severity of this disorder, BED is associated with increased health care utilization and related 
costs,15 often years before being diagnosed with BED.17  
 
EPIDEMIOLOGY 
BED is the most prevalent eating disorder. A representative community-based investigation of 
36,306 adults in the US with a primary focus on alcohol use disorder documented prevalence 
estimates of lifetime BED according to the DSM-5 of 0.9%, and twelve-month estimates of 
0.4%.16 In a further representative community sample of 6,041 Australian adolescents and 
adults, the point prevalence of BED (DSM-5) amounted to 5.6%.18 In addition, BED of low 
frequency and/or limited duration had a prevalence rate of 6.9%. Other population-based 
prevalence estimates of BED tend to fall in-between these rates.19  
 BED presents with a distinct sociodemographic profile, when compared to anorexia 
nervosa and bulimia nervosa, including a more balanced gender ratio, higher rates of obesity, 
later age of onset, and longer duration of eating disorder symptoms.19 For example, Udo and 
Grilo found a 2-3 times increased odds for women to be affected by BED than men, a more 
than two-fold increased odds for obesity, a mean age of onset of 24.5 years, and a mean 
duration of eating disorder symptoms of 15.9 years.16 BED generally occurs among diverse 
ethnic and/or racial backgrounds.20 Longitudinal developmental community studies suggest a 
peak onset of BED in early adolescence in addition to a peak onset in early adulthood.21,22  
 
ETIOLOGY 
BED develops along a complex etiology involving multiple psychological, biological, and 
sociocultural influences.23 Retrospective correlates of risk for BED were mostly shared with 
the other eating disorders, and included premorbid negative affectivity, perfectionism, 
conduct problems, substance abuse, childhood obesity, family weight concerns and eating 
problems, parenting problems and family conflict, parental psychopathology, and physical 
and sexual abuse.24  
 A few longitudinal studies on the onset of BED indicated that childhood loss of 
control eating predicts development of BED in adolescence.25,26 Risk factors longitudinally 
predicting BED onset in young women were overeating, body dissatisfaction, dieting, 
negative affect, and mental health impairment.27 The sociocultural background of an 
idealization of thinness likely fosters perceived pressure to be thin and internalization of the 
thin ideal, which have been found to predict the onset of BED in adolescent girls.28  
 Formal genetic studies suggest a heritability of BED of about 41-57%, independent of 
obesity.29,30 Molecular genetic research focusing on genes related to reward processing, 
homeostatic control, and mood processing is limited. Candidate gene studies have indicated 
the involvement of both dopamine (e.g., DRD2) and μ-opioid (e.g., OPRM1) receptor genes 
in the etiology of BED. Thus, the risk for binge eating in BED may be conveyed through a 
hypersensitivity to reward, which is likely to foster binge eating given our current obesogenic 
environment with high availability of palatable, calorically-dense processed foods. In contrast, 
research addressing an involvement of the melanocortin 4 receptor gene (MC4R) or of the 
serotonin transporter gene (5HTT) in BED has yielded inconsistent results.  
 Overall, in light of the complex etiology of BED, prospective studies testing 
mediational and interactional models may contribute to understanding how various risk 
factors work together.  
 
MAINTENANCE  
Emotional, social, and cognitive dysfunctions have been assumed to be maintaining factors of 
BED. According to the prominent affect regulation model,31 binge-eating episodes are 
triggered by and serve to provide relief from negative affect. Indeed, descriptive, laboratory, 
and ecological momentary assessment studies confirmed binge eating in BED to be preceded 
by negative affect.32 However, no clear evidence exists that binge eating actually reduces 
negative affect. Binge-eating episodes are likely to occur against a general background of a 
reduced emotional awareness and difficulties in emotion regulation, that were significantly 
more pronounced in BED versus weight-matched controls, and similar, albeit slightly less 
pronounced than in the other eating disorders.33,34 Negative affect often arises from 
interpersonal problems that are reported more frequently by individuals with BED than 
controls.35 Interpersonal problems were cross-sectionally found to be associated with eating 
disorder psychopathology, partially mediated by negative affect, thus lending some support to 
the interpersonal model of binge eating.36 
 Binge eating is further regarded as resulting from underlying neurocognitive 
dysfunctions, including difficulties in inhibitory control and reward processing, especially in 
the processing of disorder-relevant stimuli such as food cues, as determined using behavioral 
measures.33,37-39 Neuroimaging studies, mostly based on functional magnetic resonance 
imaging, documented a related differential brain activation, for example, hypoactivity in 
prefrontal networks and hyperactivity in the medial orbitofrontal cortex when compared to 
weight-matched controls.38,39 Current research on reward-based decision-making showcased 
an impaired behavioral adaptation, including an increased switching behavior in BED when 
compared to weight-matched controls. This behavior was accompanied by reduced activation 
in the anterior insula/ventro-lateral prefrontal cortex, typically associated with reversing 
behavior, and thus potentially relevant in the maintenance of binge eating despite its adverse 
consequences.40 Negative mood seems to exacerbate inhibitory deficits in BED and resulted 
in less thorough conflict monitoring on the N2 component of EEG event-related potentials 
and in more inhibition error deficits regarding food cues in an antisaccade task than in weight-
matched and normal weight controls,41 supporting an interaction of emotional and cognitive 
factors in the maintenance of BED. 
 Neurocognitive similarities of BED and obesity with substance use disorders resulted 
in the prominent, yet controversial food addiction hypothesis, according to which certain 
foods (e.g., high-sugar, high-fat) may elicit addictive responses in vulnerable individuals with 
high impulsivity and reward sensitivity.42 Although BED, viewed as an “eating addiction,” 
and substance use disorders may share these vulnerabilities, other important characteristics 
are distinct: For example, substance use disorders are defined by specific addictive agent, 
withdrawal, or tolerance, none of which have been demonstrated regarding food.43 Further 
critical aspects are that food addiction in humans is mainly operationalized through self-report 
and has unclear clinical relevance.  
 Overall, new research on the maintenance of BED should be used to refine clinical 
maintenance models providing treatment rationales, for example, the cognitive-behavioral 
model that was developed for bulimia nervosa,44 without specifically adapting it to BED. 
Biopsychological aspects of the maintenance of binge eating await further clarification. 
 
PROGNOSIS 
Regarding long-term outcome, limited longitudinal evidence suggests that the natural course 
of BED is more variable than that in anorexia nervosa or bulimia nervosa, with tendencies 
towards recovery and relapse likely embedded in a chronic course.45,46 Further, BED seems to 
be less likely to migrate to another eating disorder diagnosis over time in community 
samples,45,47 although in some clinical samples, an increased odds of migration to other eating 
disorder diagnoses, mostly bulimia nervosa, has been noted.  
 Little is known about the long-term mental or physical health outcome of BED. 
Significant negative mental health outcomes of binge-eating behaviors in youth are depressive 
symptoms and substance use.48,49 Childhood binge-eating behaviors also predicted excess 
weight gain in adolescents,48,50 as did diagnosis of BED in young women.46 BED or binge-
eating behaviors were found to independently increase the risk of the obesity-related sequelae 
in adolescents and adults, including metabolic symptoms.7,8,50 
 
TREATMENT 
A range of psychological and pharmacological treatments for patients with BED have been 
designed and evaluated in randomized-controlled trials (RCTs), with psychotherapy, self-help 
treatment, pharmacotherapy, behavioral weight loss (BWL) treatment, and combined 
treatment representing the most frequently evaluated treatment categories. 
 
Psychotherapy 
Current meta-analyses of RCTs in patients with BED demonstrated that psychotherapy, 
specifically the most frequently used approach of cognitive-behavioral therapy (CBT), has 
significant effects on the reduction of binge-eating episodes and remission from binge eating 
when compared to inactive control groups, mostly wait-list, at post-treatment.52-54 In addition, 
psychotherapy significantly reduced eating disorder psychopathology, whereas effects on 
depression were inconsistent and weight loss effects were non-significant, indicating a 
stabilization of body weight. The long-term maintenance of effects was demonstrated in RCTs 
with CBT and interpersonal psychotherapy up to four years following treatment cessation.55,56 
A superiority of CBT over other conceptually and procedurally distinct psychotherapies that 
specifically addressed the symptomatology of BED, for example, interpersonal psychotherapy 
or psychodynamic therapy, was not found.53,57 Thus, while CBT is the most well-established 
psychotherapy for BED, other psychotherapies with specific interventions for BED may be as 
efficacious.  
 
Structured Self-help Treatment 
Structured self-help treatment has mostly applied CBT manuals in book, electronic (e.g., 
video), or Internet-based format, with or without guidance from a mental health professional. 
Meta-analyses of RCTs showed significant effects of self-help treatment on the reduction of 
binge-eating episodes and remission when compared to wait-list control conditions.53,54 As 
with psychotherapy, eating disorder psychopathology was significantly improved when 
compared to wait-list control conditions. In contrast, effects on depression were inconsistent 
and there were no significant effects on body weight. Long-term maintenance of effects in 
RCTs was found up to 24 months following treatment.56,58 In comparative RCTs of guided 
versus unguided self-help treatment, differences in efficacy were not found.53 Thus, guidance 
does not seem to be indispensable element for patients with BED, although optimal intensity 
and types of guidance require further clarification. In comparative RCTs with psychotherapy, 
self-help treatment led to lower rates of remission from binge eating at follow-up and higher 
drop-out, suggesting a lower efficacy and acceptance than in the more intense specialist 
psychotherapeutic treatment. In general, self-help treatment is a viable option helping many 
patients to fully remit from BED. It was found to be less costly than psychotherapy, however, 
not necessarily more cost-effective.59 Further work is needed in this area. 
 
Pharmacotherapy 
For pharmacotherapy of BED, the majority of RCTs used second generation antidepressants 
(e.g., fluoxetine), while a few RCTs used anticonvulsants (e.g., topiramate) and the central 
nervous system stimulant lisdexamfetamine, the only medication approved by the US Food 
and Drug Administration in 2015 for the treatment of BED.52,53,60 Meta-analytically, 
pharmacotherapy using these agents outperformed pill placebo in most RCTs, showing 
significant effects on binge-eating episodes and remission. A significant weight loss effect 
was especially demonstrated for lisdexamfetamine,52,53 while results on eating disorder 
psychopathology and depression were inconsistent. Data are lacking on long-term 
maintenance of effects and long-term administration. The incidence rate of adverse events and 
the related odds of premature discontinuation were significantly increased,53 necessitating 
careful consideration in the pharmacotherapy of BED. Of note, lisdexamfetamine is marketed 
with a limitation of use, not being suited for weight loss and having a potential of serious 
cardiovascular adverse events.  
 
Weight Loss Treatment 
Behavioral weight loss (BWL) treatment is not a treatment for BED, but represents the 
standard treatment for obesity, which is according to the 2013 Obesity Guideline generally 
indicated for individuals with BMI ≥ 30.0 kg/m2 or for individuals with BMI ≥ 25 kg/m2 (or 
increased waist circumference) and obesity-related comorbidities.61 In a few RCTs, 
psychotherapy outperformed BWL treatment in reducing binge-eating episodes and eating 
disorder psychopathology at post-treatment and led to a significantly higher remission from 
binge eating at long-term follow-up.53,62 Results were inconsistent as to whether BWL 
treatment produced a superior post-treatment weight loss outcome than psychotherapy, while 
at follow-up no differences were observed. Thus, BWL treatment was found to be less suited 
for the treatment of binge-eating symptomatology than psychotherapy. Other weight loss 
treatments that were evaluated in a few RCTs of BED are self-help weight loss treatment and 
antiobesity medications such as orlistat.53,60 Preliminary data suggest a decreased efficacy 
regarding binge-eating outcome in BED.  
 
Combined Treatment 
Combinations of CBT, BWL treatment, and/or pharmacological interventions did not show 
meta-analytical effects on binge-eating episodes and remission in RCTs, but eating disorder 
psychopathology, depression, and body weight were significantly reduced.53 In direct 
comparisons, there were no differential effects of combined treatment versus psychotherapy 
on these outcomes, but a higher attrition from treatment was found. An additive effect being 
absent, combined treatment may be offered when psychotherapy alone is insufficient. 
However, combined treatment was superior to pharmacotherapy in reducing binge-eating 
episodes, but not in weight loss.63 These results suggest that combined treatment may be 
favored over pharmacotherapy alone. 
 
Conclusions 
Psychotherapy, self-help treatment, and pharmacotherapy have empirical support in the 
treatment of BED. Because of low quality of many RCTs for BED,52,53 more high quality 
research on diverse treatment approaches is warranted, with a focus on long-term maintenance 
and comparative efficacy. Pretreatment predictors informing about which patients with BED 
show a more favorable treatment response have not consistently been identified.64 More 
research is also warranted on treatment-specific moderators, which could elucidate for whom 
a specific treatment works. The presumably most well-established treatment process factor for 
BED is rapid response.65 Rapid response, typically defined as a 65-70% reduction in binge 
eating over the first four weeks of treatment, is a positive prognostic indicator of sustained 
remission from binge eating across a range of psychotherapeutic and self-help treatment 




Despite these clinical advances, BED is still not sufficiently being recognized, diagnosed, and 
treated.67 For example, Kessler et al. documented in 24,124 adults from 14 countries that only 
38.3% of lifetime cases with BED ever received a specific treatment for their eating 
disorder.20 This “treatment gap” may be attributable to multiple system factors (e.g., lack of 
screening for eating disorders) and patient factors (e.g., lack of information, perceived stigma, 
shame).68 Contributing to this gap, BED is publicly perceived as less impairing than the other 
eating disorders and attributable to a lack of self-discipline, which forms the basis of the 
stigma associated with BED.69 Although it remains unclear how these stereotypes affect 
health care professionals’ interventions for patients with BED, on the patients’ side, perceived 
stigma is one major barrier to seek help for an eating disorder such as BED.70 In addition, a 
“research-practice gap” was identified, including a discrepancy between evidence-based 
treatments and actual treatment delivery: For example, eating disorder therapists commonly 
offer eclectic combinations of interventions, not adhering to evidence-based treatment 
protocols.71 These results highlight a substantial challenge of disseminating and implementing 
evidence-based treatments for BED into clinical practice.  
 In order to further increase the efficacy of evidence-based treatments for BED, current 
research on the nature or maintenance of this disorder warrants translation into new 
interventions and/or treatments. For example, interventions to improve inhibitory control, 
especially regarding disorder-relevant stimuli, may have potential, including technology-
assisted bias modification training,72 cue exposure,73 or non-invasive neuromodulation using 
EEG neurofeedback.74  
 Regarding the classification of BED, further evidence is needed on its reliability and 
validity, taking into account the changes to diagnostic criteria in DSM-5 and ICD-11. 
Difficulties exist in the differentiation of BED from other eating disorders, for example, 
bulimia nervosa with non-purging compensatory behaviors. More research is warranted on the 
operationalization of diagnostic criteria, especially binge eating with its components of loss of 
control and size, the behavioral abnormalities, and severity rating. In addition, overvaluation 
of shape and weight, characteristic of the majority but not all individuals with BED, has been 
recommended, for example, as a diagnostic specifier, indicating greater illness severity.75  
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